Kennedy Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,418
| Closed | -$226K | – | 691 |
|
|
2024
Q4 | $226K | Sell |
13,418
-81,131
| -86% | -$1.36M | 0.01% | 656 |
|
|
2024
Q3 | $1.53M | Buy |
94,549
+4,615
| +5% | +$74.7K | 0.03% | 548 |
|
|
2024
Q2 | $739K | Buy |
+89,934
| New | +$739K | 0.02% | 610 |
|
|
2014
Q3 | – | Sell |
-4,878
| Closed | -$177K | – | 777 |
|
|
2014
Q2 | $177K | Sell |
4,878
-53,370
| -92% | -$1.94M | ﹤0.01% | 735 |
|
|
2014
Q1 | $2.26M | Buy |
58,248
+15,947
| +38% | +$619K | 0.04% | 518 |
|
|
2013
Q4 | $1.21M | Buy |
42,301
+16,397
| +63% | +$467K | 0.02% | 631 |
|
|
2013
Q3 | $927K | Buy |
+25,904
| New | +$927K | 0.02% | 644 |
|